Hascosept Forte

Hascosept Forte is an over‑the‑counter oral product that contains the active ingredient benzydamine hydrochloride. It is formulated for oromucosal administration, though the exact dosage form and strength are not disclosed on the label. Classified as a non‑steroidal anti‑inflammatory drug (NSAID), Hascosept Forte is marketed in the European Union for local relief of inflammation, pain and irritation in the mouth and throat and is intended for short‑term use.

Hascosept Forte is indicated for several common oral and pharyngeal conditions where local inflammation or pain is present, providing symptomatic relief through topical action.

- Sore throat associated with minor infections or irritation. - Oral mucositis, such as that occurring during chemotherapy or radiotherapy. - Stomatitis, including aphthous ulcers and other inflammatory lesions of the oral mucosa. - Minor gingivitis or inflamed gums causing discomfort. - Post‑operative oral discomfort following dental procedures. - Dry mouth discomfort accompanied by mild inflammation of the palate. - Mild inflammatory reactions after orthodontic appliance adjustment.

The local application of benzydamine hydrochloride may be associated with a range of adverse effects, most of which are mild and transient. These effects are generally localized to the mouth and throat and resolve without specific treatment.

Common: - Transient burning or stinging sensation at the site of application. - Mild taste alteration or metallic aftertaste. - Temporary dryness of the mouth. - Slight reddening of the oral mucosa. - Mild irritation or itching of the gums. - Temporary increase in salivation.

Serious: - Allergic reactions such as swelling of the lips, tongue or face. - Severe rash or urticaria indicating possible hypersensitivity. - Persistent ulceration of the oral mucosa requiring medical evaluation.

When using Hascosept Forte, certain precautions should be observed to minimize risk and ensure appropriate use.

- Do not use if you have a known hypersensitivity to benzydamine or any component of the product. - Avoid prolonged or excessive application beyond the recommended duration. - Keep the product out of reach of children; accidental ingestion may cause adverse effects. - If symptoms persist for more than a few days, discontinue use and seek professional advice. - Do not apply to broken skin or open wounds in the oral cavity. - Consult a healthcare professional before use during pregnancy or lactation, as safety data are limited.

Benzydamine hydrochloride may interact with other topical or systemic agents; awareness of potential interactions helps avoid reduced efficacy or increased adverse effects.

Avoid: - Concurrent use with other oral NSAIDs or analgesic mouthwashes that contain similar active ingredients. - Application together with alcohol‑based oral rinses, which may increase mucosal irritation.

Use with caution: - Use cautiously with systemic anticoagulants, as benzydamine may have mild platelet‑inhibiting effects. - Combine with other local anesthetics; additive numbness may occur. - When using other medications that cause dry mouth, monitor for increased irritation. - If the patient is receiving corticosteroid therapy, monitor for possible additive immunosuppressive effects.